At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 355 enrolled
Drug / intervention
pitavastatin +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Study of Pitavastatin Vs. Simvastatin (Following Up-Titration) in Patients With Primary Hypercholesterolemia or Combined Dyslipidemia and 2 or More Risk Factors for Coronary Heart Disease
In Brief
A Phase 3 clinical trial evaluating pitavastatin and simvastatin for Hypercholesterolemia and Dyslipidemia. Completed, enrolled 355 participants across 35 sites in 4 countries.
Detailed Summary
The purpose of this study is to compare the efficacy and safety of pitavastatin with that of simvastatin in patients with risk factors for heart disease.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHypercholesterolemia, Dyslipidemia
CountriesDenmark, Netherlands, Spain, Sweden
Collaborators--
Timeline
Phase 3CompletedFinished
2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartSep 2005
First PostedApr 2006
Primary CompletionOct 2006
TodayJul 2026
First PostedApr 3, 2006
Enrollment StartSep 1, 2005
Primary CompletionOct 1, 2006
TodayJul 2, 2026
Enrollment to primary: 1.1 yearsPosted 20.2 years ago
Interventions
pitavastatindrug
simvastatindrug